MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins - PubMed (original) (raw)
. 1999 Oct 15;59(20):5075-8.
Affiliations
- PMID: 10537276
MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins
C H Yam et al. Cancer Res. 1999.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation in many cell types, and acquisition of TGF-beta resistance has been linked to tumorigenesis. One class of proteins that plays a key role in the TGF-beta signal transduction pathway is the SMAD protein family. MDM2, a key negative regulator of p53, has recently been shown to suppress TGF-beta-induced growth arrest in a p53-independent manner. Here we show that MDM2 and the structurally related protein MDMX can inhibit the transcriptional activity of ectopically expressed SMAD1, SMAD2, SMAD3, and SMAD4. Immunofluorescence staining indicated that ectopically expressed SMAD4 was present in both the cytoplasm and nucleus, and MDM2 and NIDMX were localized mainly to the nucleus and cytoplasm, respectively. When SMAD4 was coexpressed with either MDM2 or MDMX, nuclear accumulation of SMAD4 was strikingly inhibited. We have no evidence that SMAD4 binds directly to MDM2 or MDMX; hence, the inactivation and nuclear exclusion of SMAD4 by MDM2/MDMX may involve other indirect mechanisms.
Similar articles
- MdmX inhibits Smad transactivation.
Kadakia M, Brown TL, McGorry MM, Berberich SJ. Kadakia M, et al. Oncogene. 2002 Dec 12;21(57):8776-85. doi: 10.1038/sj.onc.1205993. Oncogene. 2002. PMID: 12483531 - MDM2 and MDMX can interact differently with ARF and members of the p53 family.
Wang X, Arooz T, Siu WY, Chiu CH, Lau A, Yamashita K, Poon RY. Wang X, et al. FEBS Lett. 2001 Feb 16;490(3):202-8. doi: 10.1016/s0014-5793(01)02124-x. FEBS Lett. 2001. PMID: 11223036 - TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP, Mikkola D, Willson JK, Markowitz S. Fink SP, et al. Oncogene. 2003 Mar 6;22(9):1317-23. doi: 10.1038/sj.onc.1206128. Oncogene. 2003. PMID: 12618756 - Mdmx as an essential regulator of p53 activity.
Marine JC, Jochemsen AG. Marine JC, et al. Biochem Biophys Res Commun. 2005 Jun 10;331(3):750-60. doi: 10.1016/j.bbrc.2005.03.151. Biochem Biophys Res Commun. 2005. PMID: 15865931 Review. - The p53 and Mdm2 families in cancer.
Michael D, Oren M. Michael D, et al. Curr Opin Genet Dev. 2002 Feb;12(1):53-9. doi: 10.1016/s0959-437x(01)00264-7. Curr Opin Genet Dev. 2002. PMID: 11790555 Review.
Cited by
- Specialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor.
Fung TK, Ma HT, Poon RY. Fung TK, et al. Mol Biol Cell. 2007 May;18(5):1861-73. doi: 10.1091/mbc.e06-12-1092. Epub 2007 Mar 7. Mol Biol Cell. 2007. PMID: 17344473 Free PMC article. - High levels of Hdmx promote cell growth in a subset of uveal melanomas.
de Lange J, Teunisse AF, Vries MV, Lodder K, Lam S, Luyten GP, Bernal F, Jager MJ, Jochemsen AG. de Lange J, et al. Am J Cancer Res. 2012;2(5):492-507. Epub 2012 Aug 20. Am J Cancer Res. 2012. PMID: 22957303 Free PMC article. - Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.
Migliorini D, Lazzerini Denchi E, Danovi D, Jochemsen A, Capillo M, Gobbi A, Helin K, Pelicci PG, Marine JC. Migliorini D, et al. Mol Cell Biol. 2002 Aug;22(15):5527-38. doi: 10.1128/MCB.22.15.5527-5538.2002. Mol Cell Biol. 2002. PMID: 12101245 Free PMC article. - MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.
Ganguli G, Abecassis J, Wasylyk B. Ganguli G, et al. EMBO J. 2000 Oct 2;19(19):5135-47. doi: 10.1093/emboj/19.19.5135. EMBO J. 2000. PMID: 11013216 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous